Position in JNJ
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$2,814,749
+$263,040 QoQ
Shares Held
11,083
+6.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
#2,041
of 4,664 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ALBION FINANCIAL GROUP /UT holds $22,152,027 across 13 Drug Manufacturers - General names. JNJ ranks #4 (12.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
24,267 | $8,787,566 | |
| 2 | ABBV |
AbbVie Inc.
|
18,850 | $4,743,414 | |
| 3 | MRK |
Merck & Co., Inc.
|
30,544 | $3,924,904 | |
| 4 | JNJ |
Johnson & Johnson
This page
|
11,083 | $2,814,749 | |
| 5 | LLY |
ELI LILLY & Co
|
1,246 | $1,494,489 | |
| 6 | PFE |
Pfizer Inc
|
7,059 | $169,980 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
577 | $72,898 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
800 | $46,096 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,814,749 | 11,083 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $2,551,709 | 10,439 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $1,931,050 | 9,331 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $1,725,889 | 9,308 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $1,347,866 | 8,824 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $1,496,540 | 9,024 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $1,301,146 | 8,997 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $1,490,465 | 9,197 | Shares | Sole | 2024-10-09 | |
| 2024-06-30 | $1,282,846 | 8,777 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $1,388,433 | 8,777 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $1,375,706 | 8,777 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $1,394,897 | 8,956 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $1,505,569 | 9,096 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $1,409,880 | 9,096 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $1,633,305 | 9,246 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $1,551,920 | 9,500 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $1,686,345 | 9,500 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $1,696,800 | 9,574 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $1,667,419 | 9,747 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $2,073,337 | 12,838 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $2,144,750 | 13,019 | Shares | Sole | 2021-08-12 | |
| 2020-12-31 | $1,827,653 | 11,613 | Shares | Sole | 2021-02-19 | |
| 2020-09-30 | $1,645,570 | 11,053 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,623,995 | 11,548 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $1,528,582 | 11,657 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||